Related Experiment Video
Updated: Sep 27, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.3K
Applications and Challenges of Machine Learning Methods in Alzheimer's Disease Multi-Source Data Analysis
Xiong Li1, Yangping Qiu1, Juan Zhou1
1School of Software, East China Jiaotong University, Nanchang, 330013, China.
Current Genomics
|April 7, 2022
Summary
Machine learning advances Alzheimer's disease (AD) research by analyzing complex neuroimaging and omics data for early diagnosis. This review covers ML applications, challenges, and future directions in multi-modal AD data analysis.
Area of Science:
- Computational neuroscience
- Bioinformatics
- Medical imaging analysis
Background:
- Neuroimaging and genetic technologies enable in vivo measurement of Alzheimer's disease (AD) pathological features.
- High-dimensional, multi-modal neuroimaging and omics data analysis is crucial for identifying AD biomarkers.
- Machine learning (ML) methods are increasingly applied to large-scale AD biomedical data for discovering pathogenic mutations and mechanisms.
Purpose of the Study:
- To review and summarize the applications of ML in analyzing multi-source data for Alzheimer's disease.
- To identify current challenges and future research directions in ML-driven AD data analysis.
Main Methods:
- Literature search conducted on Google Scholar, PubMed, and Web of Science.
- Keywords included Alzheimer's disease, bioinformatics, image genetics, genome-wide association research, molecular interaction network, and multi-omics data integration.
- Comprehensive review of ML techniques applied to AD neuroimaging and omics data.
Main Results:
- ML techniques are successfully applied to AD neuroimaging data processing.
- Progress in computational analysis methods for omics data (genome, proteome) in AD is demonstrated.
- ML methods for AD imaging analysis are summarized.
Conclusions:
- Emerging technologies focus on joint analysis of multi-modal neuroimaging and multi-omics data for AD.
- Outstanding issues and future research directions in ML for AD are highlighted.
- ML offers a powerful approach for advancing early diagnosis and understanding of AD pathogenesis.
Related Concept Videos
Alzheimer's Disease: Overview
705
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
705
Alzheimer's Disease: Treatment
274
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
274

